<SEC-DOCUMENT>0001628280-25-032457.txt : 20250620
<SEC-HEADER>0001628280-25-032457.hdr.sgml : 20250620
<ACCEPTANCE-DATETIME>20250620165952
ACCESSION NUMBER:		0001628280-25-032457
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250618
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250620
DATE AS OF CHANGE:		20250620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		251062134

	BUSINESS ADDRESS:	
		STREET 1:		100 INTERNATIONAL DRIVE
		STREET 2:		18TH FLOOR
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21202
		BUSINESS PHONE:		4105818042

	MAIL ADDRESS:	
		STREET 1:		100 INTERNATIONAL DRIVE
		STREET 2:		18TH FLOOR
		CITY:			BALTIMORE
		STATE:			MD
		ZIP:			21202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>med-20250618.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a39e9482-de6a-4a85-ae00-b3531b191c37,g:02f5c004-2ec6-4ffd-abf5-acc3458a9ac7,d:6dcb204d0ace4160908e1364712de010-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20250618</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20250618.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-18</xbrli:startDate><xbrli:endDate>2025-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-18</xbrli:startDate><xbrli:endDate>2025-06-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6dcb204d0ace4160908e1364712de010_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">June 18, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">MEDIFAST, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-31573</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">13-3714405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">100 International Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">410</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-13">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-14">MED</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:96.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:324pt;text-align:right;text-indent:-324pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="i6dcb204d0ace4160908e1364712de010_7"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02. &#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 18, 2025, as described below under Item 5.07 of this Current Report on Form 8-K, the stockholders of Medifast, Inc. (the "Company") approved an amendment to the Amended and Restated 2012 Share Incentive Plan (the "2012 Plan") primarily to increase the number of shares of the Company's common stock authorized for issuance under the 2012 Plan by 550,000 shares (as amended, the &#8220;Amended 2012 Plan&#8221;) at the Company&#8217;s 2025 annual meeting of stockholders (the "Annual Meeting"). The Amended 2012 Plan became effective immediately upon stockholder approval at the Annual Meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of the material terms of the Amended 2012 Plan is included in the Company&#8217;s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 29, 2025 (the &#8220;Proxy Statement&#8221;), under the section captioned "PROPOSAL 4 - APPROVAL OF THE AMENDED AND RESTATED 2012 SHARE INCENTIVE PLAN," which description is incorporated herein by reference. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The descriptions of the Amended 2012 Plan contained herein and in the Proxy Statement are not complete and are qualified in their entireties by the full text of the Amended 2012 Plan, a copy of which is filed hereto as Exhibit 10.1 and incorporated herein by reference. </span></div><div id="i6dcb204d0ace4160908e1364712de010_10"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.07.&#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the Annual Meeting, the stockholders voted on the following four proposals and cast their votes as described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(i) The number of shares voted and broker non-votes for the directors nominated for re-election to the Board are set forth below. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Director Name</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">For</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstained</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey J. Brown</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,046,608</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,731</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,471</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,961,959</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,118</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,733</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth A. Geary</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,845,990</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,620</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,200</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael A. Hoer</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,040,159</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,195</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,456</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott Schlackman</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,039,147</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,910</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,753</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrea B. Thomas</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,778,243</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,298</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ming Xian</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,779,065</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398,124</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,621</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, each of the individuals listed above was re-elected to the Company&#8217;s Board of Directors, each to hold office until the Company&#8217;s next annual meeting of stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) The stockholders voted on a proposal to ratify the appointment of RSM US LLP as the Company&#8217;s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposal was approved by a vote of stockholders as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">For:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,225,570</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,619</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstained:</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,428</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) The stockholders voted on a proposal to approve, on an advisory basis, the compensation of the Company&#8217;s named executive officers as set forth in the proxy statement for the Annual Meeting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposal was approved by a vote of the stockholders as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">For:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585,469</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477,849</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstained:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,492</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes:</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv) The stockholders voted on a proposal to approve the Amended 2012 Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposal was approved by a vote of the stockholders as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.766%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">For:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518,075</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Against:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,416</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Abstained:</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,319</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Broker Non-Votes:</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,093,807</span></td></tr></table></div><div id="i6dcb204d0ace4160908e1364712de010_13"></div><div style="margin-top:12pt"><span><br/></span></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibits.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2012amendedandrestatedsha.htm">Amended and Restated 2012 Share Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i6dcb204d0ace4160908e1364712de010_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.708%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEDIFAST, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: June 20, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a2012amendedandrestatedsha.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="iaca8fc317ec34a2faecbdf73a79b124e_37"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2012 SHARE INCENTIVE PLAN</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Purpose</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of this Amended and Restated 2012 Share Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) of Medifast, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), is to advance the interests of the Company and its stockholders by providing a means to attract, retain, and reward executive officers and other key individuals of the Company and&#47;or its subsidiaries, to link compensation to measures of the Company&#8217;s performance in order to provide additional share- based incentives to such individuals for the creation of stockholder value, and to promote ownership of a greater proprietary interest in the Company, thereby aligning such individuals&#8217; interests more closely with the interests of stockholders of the Company.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The definitions of awards under the Plan, including Options, SARs (including Limited SARs), Restricted Shares, Deferred Shares, and Shares granted as a bonus or in lieu of other awards are set forth in Section 6 of the Plan. Such awards, together with any other right or interest granted to a Participant under the Plan, are termed &#8220;Awards.&#8221; The definitions of terms relating to a Change in Control of the Company are set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Plan. In addition to such terms and the terms defined in Section 1, the following are defined terms under the Plan&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any written agreement, contract, notice to a Participant, or other instrument or document evidencing an Award.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the person, persons, trust, or trusts which have been designated by a Participant in his or her most recent written beneficiary designation filed with the Committee to receive the benefits specified under this Plan upon such Participant&#8217;s death. If, upon a Participant&#8217;s death, there is no designated Beneficiary or surviving designated Beneficiary, then the term Beneficiary means the Participant&#8217;s estate.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended from time to time. References to any provision of the Code include regulations thereunder and successor provisions and regulations thereto.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Board, and&#47; or such other Board committee as may be designated by the Board to administer the Plan.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended from time to time. References to any provision of the Exchange Act include the rules promulgated thereunder and successor provisions and rules thereto.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Fair Market Value</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of a Share means, as of any given date, the closing sales price of a Share on the New York Stock Exchange for such date or, if such day was not a trading day, the closing sales price for the most recent trading day prior to such date.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who, as an executive officer, director, key employee or key independent contractor of the Company or a subsidiary, has been granted an Award under the Plan which remains outstanding.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the objective goal or goals applicable to a Participant&#8217;s Awards that are deemed by the Committee to be important to the success of the Company or any subsidiaries of the Company. The Committee shall establish the specific objective measures for each applicable goal for a performance period, which need not be uniform with respect to each Participant. In creating these measures, the Committee may use one or more of the following business criteria&#58; (i) earnings before or after interest, taxes, depreciation and amortization, (ii) earnings before or after interest, taxes, depreciation and amortization expressed as a percentage of net sales, (iii) earnings per share, (iv) operating cash flow, (v) return on invested capital, (vi) return on stockholders' equity, (vii) market price per share, measured either in absolute terms or as compared to a peer group, (viii) net sales or net revenue, (ix) return on net sales, (x) profit margin, gross or net, (xi) operating margin, (xii) productivity, (xiii) working capital efficiency, (xiv) expense control or (xv) any other criteria determined to be appropriate by the Committee. The business criteria may apply to the individual, a division, a component of the Company&#8217;s business, or to the Company and&#47;or one or more subsidiaries of the Company and may be weighted and expressed in absolute terms or relative to the performance of other individuals or companies or an index.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rule 16b-3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Exchange Act Rule 16b-3 as from time to time in effect and applicable to the Plan and Participants.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Common Share of the Company and such other securities as may be substituted for such Share or such other securities pursuant to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that to the extent any class of common shares are readily tradable on an established securities market, such common shares shall be designated as the Shares for purposes of this Plan.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means&#58; (i) with respect to an Award granted to an employee, the termination of the employment relationship between the employee and the Company and all Company subsidiaries, (ii) with respect to an Award granted to an independent contractor, the termination of the service arrangement between the independent contractor and the Company and all Company subsidiaries, and (iii) with respect to an Award granted to a non-employee director, the cessation of the provision of services as a director of the Company and all Company subsidiaries&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if the Participant&#8217;s status changes from employee, independent contractor, or non-employee director to any other status eligible to receive Awards under the Plan, the Committee may provide that no Termination of Service occurs for purposes of the Plan until the Participant&#8217;s new status with the Company and all Company subsidiaries terminates. For purposes of this subsection, if a Participant&#8217;s relationship is with a Company subsidiary, and not the Company (i.e., the Participant is an employee, independent contractor, or non-employee director of a Company subsidiary and not the Company), the Participant shall incur a Termination of Service when such entity ceases to be a Company subsidiary, unless the Committee determines otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Composition of Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall consist solely of two or more individuals each of whom shall be a &#8220;nonemployee director&#8221; as defined in Rule l6b-3. If the Committee cannot or does not act, the Board shall have the rights and responsibilities of the Committee hereunder and under the Award Agreements.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Authority of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee. The Committee shall have full and final authority to take the following actions, in each case subject to and consistent with the provisions of the Plan&#58;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to select Participants to whom Awards may be granted&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to determine the type or types of Awards to be granted to each Participant&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to determine the number of Awards to be granted, the number of Shares to which an Award will relate, the terms and conditions of any Award granted under the Plan (including, but not limited to, the exercise price, grant price, or purchase price, any restriction or condition, any schedule or performance conditions for the lapse of restrictions or conditions relating to transferability, forfeiture before or after grant, exercisability, or settlement of an Award, and waivers, accelerations, or modifications thereof, based in each case on such considerations as the Committee shall determine), and all other matters to be determined in connection with an Award&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to determine whether, to what extent, and under what circumstances an Award may be settled, or the exercise price of an Award may be paid, in cash, Shares, other Awards, or other property, or an Award may be canceled, forfeited, or surrendered&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-16.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to prescribe the form of each Award Agreement, which need not be identical for each Participant&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to adopt, amend, suspend, waive, and rescind such rules and regulations and appoint such agents as the Committee may deem necessary or advisable to administer the Plan&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-22.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to correct any defect or supply appropriate text for any omission or reconcile any inconsistency in the Plan and to construe and interpret the Plan and any Award, rules and regulations, Award Agreement, or other instrument hereunder, with such constructions and interpretations to be conclusive and binding on all persons and otherwise accorded the maximum deference permitted by law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, the Committee&#8217;s construction and interpretation shall not be entitled to deference on and after a Change in Control except to the extent that such constructions and interpretations are made exclusively by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">members of the Committee who are individuals who served as Committee members before the Change in Control&#59;</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-24.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">viii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">to make all other decisions and determinations as may be required under the terms of the Plan or as the Committee may deem necessary or advisable for the administration of the Plan&#59; and</font></div><div style="padding-left:108pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ix.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">In the event of any dispute or disagreement as to the interpretation of the Plan or of any rule, regulation or procedure, or as to any question, right or obligation arising from or related to the Plan, the decision of the Committee, except as provided in clause (vii), shall be final and binding upon all persons. Unless otherwise expressly provided hereunder, the Committee, with respect to any grant, may exercise its discretion hereunder at the time of the Award or thereafter.</font></div><div style="padding-left:108pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Manner of Exercise of Committee Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless authority is specifically reserved to the Board under the terms of the Plan, the Company&#8217;s bylaws, or applicable law, the Committee shall have discretion to exercise authority under the Plan. Any action of the Committee with respect to the Plan shall be final, conclusive, and binding on all persons, including the Company, subsidiaries of the Company, Participants, any person claiming any rights under the Plan from or through any Participant, and stockholders. The express grant of any specific power to the Committee, and the taking of any action by the Committee, shall not be construed as limiting any power or authority of the Committee. To the extent permitted by applicable law, the Committee may delegate to officers or employees of the Company or any subsidiary the authority, subject to such terms as the Committee shall determine, (i) to perform administrative functions, (ii) with respect to Participants not subject to Section 16 of the Exchange Act, to perform such other functions of the Committee as the Committee may determine, and (iii) with respect to Participants subject to Section 16, to perform such other functions of the Committee as the Committee may determine to the extent performance of such functions will not result in the loss of an exemption under Rule 16b-3 otherwise available for transactions by such persons. If and to the extent applicable, no member of the Committee may act as to matters under the Plan specifically relating to such member. If no Committee is designated by the Board to act for these purposes, the Board shall have the rights and responsibilities of the Committee hereunder and under the Award Agreements.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Limitation of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each member of the Committee shall be entitled to in good faith, rely or act upon any report or other information furnished to him by any officer or other employee of the Company or any subsidiary, the Company&#8217;s independent certified public accountants, or any executive compensation consultant, legal counsel, or other professional retained by the Company to assist in the administration of the Plan. No member of the Committee, nor any officer or employee of the Company acting on behalf of the Committee, shall be personally liable for any action, determination, or interpretation taken or made in good faith with respect to the Plan, and all members of the Committee and any officer or employee of the Company acting on behalf of the Committee or members thereof shall, to the extent permitted by law or charter, be fully indemnified, held harmless and protected by the Company with respect to any such action, determination, or interpretation.</font></div><div style="padding-left:23pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Shares Available Under Plan&#59; Individual Award Limitations&#59; Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Shares Reserved for Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to adjustment as hereinafter provided, the total number of Shares reserved and available for issuance to Participants in connection with Awards (including with respect to ISOs) under the Plan shall increase by 550,000 Shares to approximately 1,175,000 Shares&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the number of Shares with respect to which (i) Awards of Options (including ISOs) and SARs may be granted to any Participant shall in each case not exceed 75,000 during any calendar year and (ii) Awards of Restricted Shares, Deferred Shares and Shares may be granted to any non-employee Director, shall in each case not exceed 150,000 during any calendar year. If all or any portion of an Award is forfeited, settled in cash, or terminated without issuance of Shares to the Participant, the Shares to which such Award or portion thereof related shall again be available for future Awards under the Plan. Notwithstanding anything to the contrary contained herein, Shares subject to an Option or SAR under this Plan shall not again be available for </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issuance under this Plan if such Shares are (i) Shares tendered, withheld or surrendered in payment of the exercise or purchase price of an Option or SAR or tax obligations relating to Award, (ii) Shares that were not issued or delivered as a result of the net settlement or net exercise of an Option or SAR or (iii) Shares repurchased on the open market with the proceeds of an Option&#8217;s exercise price. The Committee may adopt procedures for the counting of Shares relating to any Award to ensure appropriate counting and avoid double counting (in the case of tandem or substitute awards). Any Shares issued pursuant to an Award may consist, in whole or in part, of authorized and unissued Shares, treasury Shares, or Shares acquired in the market for the account of the Participant (which treasury Shares or acquired Shares will be deemed to have been &#8220;issued&#8221; pursuant to such Award).</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Adjustments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">In the event that the Committee shall determine that any recapitalization, reorganization, merger, consolidation, spin-off, combination, repurchase, exchange of Shares or other securities of the Company, stock split or reverse split, extraordinary dividend (whether in the form of cash, Shares, or other property), liquidation, dissolution, or other similar corporate transaction or event affects the Shares such that an adjustment is appropriate in order to prevent dilution or enlargement of each Participant&#8217;s rights under the Plan, then the Committee shall, in such manner as it may deem equitable, adjust any or all of (i) the number and kind of Shares remaining reserved and available for issuance under </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, (ii) the number and kind of outstanding Restricted Shares or Restricted Shares relating to any other outstanding Award in connection with which Restricted Shares may be issued, (iii) the number and kind of Shares that may be issued in respect of other outstanding Awards, and&#47;or (iv) the exercise price or grant price relating to any Award (or, if deemed appropriate, the Committee may make provision for a cash payment with respect to any outstanding Award). In addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, events described in the preceding sentence) affecting the Company or any subsidiary or the financial statements of the Company or any subsidiary, or in response to changes in applicable laws, regulations, or accounting principles&#59; or in the event the Committee determines that such adjustments are appropriate in order to prevent dilution or enlargement of benefits or potential benefits intended to be made available under the Plan.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">If the Company shall be consolidated or merged with another corporation or other entity, each Participant who has received Restricted Shares that are then subject to restrictions imposed by Section 6(d) may be required to deposit with the successor corporation the certificates for the stock or securities or the other property that the Participant is entitled to receive by reason of ownership of Restricted Shares in a manner consistent with </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(d)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and such stock, securities or other property shall become subject to the restrictions and requirements imposed by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the certificates therefor or other evidence thereof shall bear a legend similar in form and substance to the legend referred to in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(d)(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">The judgment of the Committee with respect to any matter referred to in this sub-section (b) shall be conclusive and binding upon each Participant without the need for any amendment to the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:3.45pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as provided in the following sentence, Executive officers, other key employees and other key independent contractors of the Company and its subsidiaries, including any director and any director who is also an executive officer or employee, are eligible to be granted Awards under the Plan. Notwithstanding the preceding sentence, only Executive officers and other key employees of the Company and its &#8220;subsidiary corporation&#8221; (as such term is defined in Section 424(f) of the Code) are eligible to be granted ISOs under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Specific Terms of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards may be granted on the terms and conditions set forth in this Section 6. In addition, the Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter (subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine, including terms requiring forfeiture of Awards in the event of Termination of Service by the Participant or upon the occurrence of other events. In addition, the Committee shall require, as the condition of the issuance of Shares in connection with any Award, that consideration be received by the Company which meets the requirements of the Delaware General Corporation Law.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Option entitles a Participant to purchase a Share on the exercise thereof. Options include ISOs and NQSOs. An ISO is an Option that is intended to meet the requirements of Section 422 of the Code. An NQSO is an Option that is not an ISO. The Committee is authorized to grant Options to Participants on the following terms and conditions&#58;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exercise price per Share purchasable under an Option shall be determined by the Committee at the time of grant but shall be not less than 100% (110% in the case of an ISO granted to a more-than-ten-percent stockholder, as provided in clause (vi) below) of Fair Market Value on the date of grant of the Option.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of each Option shall be determined by the Committee and shall not exceed ten years (five years in the case of an ISO granted to a more-than-ten-percent stockholder (as provided in clause (vi) below)).</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Time and Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine the time or times at which an Option may be exercised in whole or in part, the methods by which such exercise price may be paid or deemed to be paid, the form of such payment, including, without limitation, cash, Shares, cashless exercise and&#47;or a broker-assisted exercise, and the methods by which Shares will be delivered or deemed to be delivered to Participants.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Committee, upon Termination of Service during the applicable term of the Options, unexercised Options shall be forfeited and again be available for Award by the Company. The Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that forfeiture conditions relating to the Options will be waived in whole or in part in the event of terminations resulting from specified causes.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-16.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">ISO Annual Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The aggregate Fair Market Value (determined as of the date the ISO is granted) of the Shares with respect to which the ISOs are exercisable for the first time by a Participant during any calendar year (counting ISOs under this Plan and under any stock option plan of the Company or a parent or subsidiary corporation of the Company (as defined in Sections 424(e) and (f) of the Code) shall not exceed $100,000. If an Option intended as an ISO is granted to a Participant and the Option may not be treated in whole or in part as an ISO pursuant to the $100,000 limit, the Option shall be treated as an ISO to the extent it may be so treated under the limit and as an NQSO as to the remainder. For purposes of determining whet her an ISO would cause the limitation to be exceeded, ISOs shall be taken into account in the order granted.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">More-Than Ten-Percent Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If, after applying the attribution rules of Section 424(d) of the Code, the Participant owns stock possessing more than ten percent of the total combined voting power of all classes of stock of the Company or of a parent or subsidiary corporation of the Company (as defined in Sections 424(e) and (f) of the Code) immediately before an ISO is granted to him or her, the exercise price for the ISO shall be not less than 110 percent of the Fair Market Value of the optioned Shares on the date the ISO is granted, and such ISO, by its terms, shall not be exercisable after the expiration of five years from the date the ISO is granted. The conditions set forth in this clause shall not apply to NQSOs.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Share Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is authorized to grant SARs to Participants on the following terms and conditions&#58;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Right to Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A SAR shall confer on the Participant to whom it is granted a right to receive, upon exercise thereof, the excess of (A) the Fair Market Value of one Share on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date of exercise, over (B) the Fair Market Value of one Share on the date of grant of the SAR.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Other Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall determine the time or times at which a SAR may be exercised in whole or in part, the method of exercise, method of settlement, form of consideration payable in settlement, method by which Shares will be delivered or deemed to be delivered to Participants, whether or not a SAR shall be in tandem with any other Award, and any other terms and conditions of any SAR. Limited SARs that may only be exercised upon the occurrence of a Change in Control (as such term is defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or as otherwise defined by the Committee) may be granted on such terms, not inconsistent with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as the Committee may determine. Such Limited SARs may be either freestanding or in tandem with other Awards.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Committee, upon Termination of Service during the applicable term of the SARs, unexercised SARs shall be forfeited and again be available for Award by the Company. The Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that forfeiture conditions relating to the SARs will be waived in whole or in part in the event of terminations resulting from specified causes.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is authorized to grant Restricted Shares to Participants on the following terms and conditions&#58;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may provide a specified purchase price for the Restricted Shares (whether or not any State law applicable to the Company requires the payment of a purchase price). Except to the extent restricted under the terms of the Plan and any Award Agreement relating to the Restricted Shares, a Participant granted Restricted Shares shall have all of the rights of a stockholder including, without limitation, the right to vote Restricted Shares and the right to receive dividends thereon (as described below). Restricted Shares include Performance Shares. Performance Shares are Restricted Shares that provide for a lapse of restrictions upon the attainment of certain Performance Goals.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Lapse of Restrictions.</font></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">In General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon the lapse of all restrictions in accordance with this subsection (d) or Section 8, Shares shall cease to be Restricted Shares for purposes of the Plan.</font></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Restricted Shares Other Than Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Restricted Shares that are not Performance Shares, the applicable restrictions shall lapse at such time or times, and on such conditions (such as performance-based requirements), as the Administrator may specify in the Award Agreement. The Administrator may at any time accelerate the time at which the restrictions on all or any part of the shares of Restricted Shares (other than Performance Shares) will lapse.</font></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Performance Shares, the applicable restrictions shall lapse at the end of the applicable performance period if and to the extent the Performance Goals have been achieved for such period. The Committee shall certify the extent to which the Performance Goals are achieved and shall have the discretion to decrease (but not increase) the extent to which such restrictions lapse on account of such achievement. The restrictions shall also lapse (A) as provided in Section 8, or (B) if and to the extent determined by the Committee, in the case of the Participant&#8217;s death or disability (as determined by the Committee). If the Participant&#8217;s Termination of Service occurs for any reason prior to the end of the performance period, the Participant shall forfeit all Performance Shares granted with respect to such performance period except (i) as provided in Section 14, (ii) as determined by the Committee in the case of the Participant&#8217;s death or disability (as determined by the Committee), or (iii) as otherwise provided by the Committee.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Committee, upon Termination of Service during the applicable restriction period, Restricted Shares that are at that time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject to restrictions shall be forfeited and reacquired by the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that restrictions or forfeiture conditions relating to Restricted Shares will be waived in whole or in part in the event of terminations resulting from specified causes.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Certificates for Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Restricted Shares granted under the Plan may be evidenced in such manner as the Committee shall determine. If certificates representing Restricted Shares are registered in the name of the Participant, such certificates shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Shares, the Company may retain physical possession of the certificate, and the Participant shall have delivered a stock power to the Company, endorsed in blank, relating to the Restricted Shares.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-16.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Dividends and Distributions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Dividends paid on Restricted Shares shall be either paid at the dividend payment date in the form the dividends are paid to other stockholders, in cash, or in unrestricted Shares having a Fair Market Value equal to the amount of such dividends, or subject to the terms of Section 409A of the Code, the payment of such dividends shall be deferred and&#47;or the amount or value thereof automatically reinvested in additional Restricted Shares, other Awards, or other investment vehicles, as the Committee shall determine or permit the Participant to elect&#59; provided that with respect to Restricted Shares (including Performance Shares) that vest based on the achievement of Performance Goals or other performance criteria, dividends shall be paid at the time and to the extent that the restrictions and risk of forfeiture on the Restricted Shares lapse. Shares distributed in connection with a Share split or Share dividend, and other property distributed as a dividend, shall be subject to restrictions and a risk of forfeiture to the same extent as the Restricted Shares with respect to which such Shares or other property are distributed.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Nature of Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Restricted Shares granted under the Plan are not intended to provide for the deferral of compensation subject to Section 409A of the Code.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Deferred Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee is authorized to grant Deferred Shares to Participants, subject to the following terms and conditions&#58;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Award and Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Deferred Share shall entitle a Participant to a Share (or its cash equivalent) on the date of vesting. Deferred Shares shall be subject to such vesting conditions as the Committee may impose, if any, which may include vesting at the expiration of the deferral period, at earlier specified times, or upon the achievement of certain Performance Goals, separately or in combination, under such circumstances, in such installments, or otherwise as the Committee may determine.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Issuance of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon meeting the vesting condition specified for an Award of Deferred Shares, the Company shall issue the Shares to which the Participant is entitled under the Award. In no event shall such issuance occur more than two and one-half months after the close of the calendar year in which the Participant&#8217;s rights to such shares vest. In the event the Award of Deferred Shares provides for partial vesting over multiple years, shares that vest during a calendar year shall be issued to the Participant within two and one-half months after the close of the calendar year in which the Shares vest.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Deferred Shares Other Than Deferred Shares That Are Subject to Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Deferred Shares that are not subject to Performance Goals, the Committee shall determine when such Deferred Shares shall vest and any conditions (such as continued employment) that must be met in order for such Deferred Shares to vest at the end of the applicable vesting period. The Committee may at any time accelerate the time at which such Deferred Shares shall vest.</font></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Deferred Shares Subject to Performance Goals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred Shares that are subject to Performance Goals shall vest at the end of the applicable performance period if and to the extent the Performance Goals have been achieved for such period. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:144pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall certify the extent to which the Performance Goals are achieved and shall the have the discretion to decrease (but not increase) the extent to which such Deferred Shares vest on account of such achievement. Such Deferred Shares shall also vest (A) as provided in Section 8, or (B) if and to the extent determined by the Committee in the case of the Participant&#8217;s death or disability (as determined by the Committee). If the Participant&#8217;s Termination of Service occurs for any reason prior to the end of the performance period, the Participant shall forfeit all such Deferred Shares granted with respect to such performance period, except (i) as provided in Section 8, (ii) as determined by the Committee in the case of the Participant&#8217;s death or disability (as determined by the Committee), or (iii) as otherwise determined by the Committee.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Forfeiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise determined by the Committee, upon Termination of Service during the applicable deferral period or portion thereof to which forfeiture conditions apply (as provided in the Award Agreement evidencing the Deferred Shares), all Deferred Shares that are at that time subject to such risk of forfeiture shall be forfeited&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may provide, by rule or regulation or in any Award Agreement, or may determine in any individual case, that restrictions or forfeiture conditions relating to Deferred Shares will be waived in whole or in part in the event of terminations resulting from specified causes.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-16.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may provide that payments in the form of dividend equivalents will be credited in respect of Deferred Shares, which amounts may be paid or distributed when accrued or deemed reinvested in additional Deferred Shares. Any dividend equivalents credited with respect to Deferred Shares shall be subject to restrictions and a risk of forfeiture to the same extent as the Deferred Shares and amounts credited shall be distributed in accordance with the provisions of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6(e)(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Compliance with Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything herein to the contrary, all distributions of Deferred Shares shall be made within the applicable &#8220;short-term deferral period&#8221; within the meaning of Section 409A of the Code.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Bonus Shares and Awards in Lieu of Cash Obligations.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Committee is authorized to grant Shares as a bonus, or to grant Shares or other Awards in lieu of Company obligations to pay cash under other plans or compensatory arrangements&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, in the case of Participants subject to Section 16 of the Exchange Act, the amount of such Shares or Awards shall be determined by the Committee in a manner conforming to then - applicable requirements of Rule 16b-3. Shares or Awards granted hereunder shall be subject to such other terms as shall be determined by the Committee.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Other Stock-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee shall have the right to grant other Awards based upon the Shares having such terms and conditions as the Committee may determine, including the grant of shares based upon certain conditions, the grant of securities convertible into Shares and the grant of phantom shares.</font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Certain Provisions Applicable to Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Stand-Alone, Additional, Tandem and Substitute Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards granted under the Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem with, or in substitution for, any other Award granted under the Plan or any award granted under any other plan of the Company, any subsidiary, or any business entity to be acquired by the Company or a subsidiary, or any other right of a Participant to receive payment from the Company or any subsidiary. Awards granted in addition to or in tandem with other Awards or awards may be granted either as of the same time as or a different time from the grant of such other Awards or awards. The per Share exercise price of any Option, grant price of any SAR, or purchase price of any other Award conferring a right to purchase Shares granted in substitution for an outstanding Award or award may be adjusted to reflect the in- the-money value of the surrendered Award or award, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such adjustment does not cause the Award to be treated as deferred compensation subject to Section 409A of the Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Term of Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The term of each Award shall be for such period as may be determined by the Committee up to a maximum term of ten years.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Form of Payment Under Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of the Plan and any applicable Award Agreement, payments to be made by the Company or a subsidiary upon the grant or exercise of an Award may be made in such forms as the Committee shall determine, including, without limitation, cash, Shares, other Awards.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Rule 16b-3 Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. It is the intent of the Company that this Plan comply in all respects with applicable provisions of Rule 16b-3 in connection with any grant of Awards to or other transaction by a Participant who is subject to Section 16 of the Exchange Act (except for transactions exempted under alternative Exchange Act Rules or acknowledged in writing to be non-exempt by such Participant). Accordingly, if, at such time, any provision of this Plan or any Award Agreement relating to an Award does not comply with the requirements of Rule 16b -3 as then applicable to any such transaction, such provision will be construed or deemed amended to the extent necessary to conform to the applicable requirements of Rule 16b-3 so that such Participant shall avoid liability under Section 16(b).</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Treatment of Dividends and Dividend Equivalents on Unvested Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan to the contrary, if dividends are declared during the period that an Award is outstanding, such dividends (or dividend equivalents) shall either (i) not be paid or credited with respect to such Award or (ii) be accumulated but remain subject to vesting requirements to the same extent as the applicable Award and shall only be paid at the time such the vesting requirements are satisfied. In no event shall dividends or dividend equivalents be paid with respect to Options or Stock Appreciation Rights prior to their exercise or settlement, as applicable.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Minimum Vesting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan to the contrary, the minimum vesting period with respect to any portion of an Award shall be no less than one year&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that Shares underlying Awards with respect to up to 5% of the total number of Shares reserved for Awards under Section 4(a) (subject to adjustment under Section 4(b)) may be exempt from the foregoing limitations. Nothing in this Section 7(j) shall limit the Company&#8217;s ability to grant Awards that contain rights to accelerated vesting upon a termination of employment or service for any reason other than for Cause or limit any rights to accelerated vesting in connection with a Change in Control, as provided in Section 8 of the Plan, in each case, prior to the completion of the minimum one-year service requirement described in the foregoing sentence. In addition, the minimum vesting requirement set forth in this Section 7(j) shall not apply to (i) an Award granted in substitution for another award, (ii) Awards granted to non-employee directors which vest on the earlier of the one-year anniversary of the date of grant and the next annual meeting of the Company&#8217;s shareholders (which is at least 50 weeks after the immediately preceding year&#8217;s annual meeting), (iii) Awards settled solely in cash in lieu of shares or (iv) Awards granted in lieu of earned cash obligations.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Change in Control Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In the event of a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; as defined in this Section, unless otherwise provided in the Award Agreement or another contract or Company-sponsored plan, in the event of a Change in Control, unless provision is made in connection with the Change in Control for (x) assumption of Awards previously granted or (y) substitution for such Awards of new awards covering stock of a successor corporation or its &#8220;parent corporation&#8221; (as defined in Section 424(e) of the Code) or &#8220;subsidiary corporation&#8221; (as defined in Section 424(f) of the Code) with appropriate adjustments as to the number and kinds of shares and the exercise prices, if applicable, the following shall occur&#58;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">the Committee as constituted immediately before the Change in Control may make such adjustments as it, in its discretion, determines are necessary or appropriate in light of the Change in Control (including, without limitation, the substitution of stock other than stock of the Company as the stock optioned hereunder, cash payment or other equitable consideration and the acceleration of vesting or exercisability of Awards under the Plan), </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Committee determines that such adjustments do not have a substantial </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adverse economic impact on the Participants as determined at the time of the adjustments, and</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">any Award carrying a right to exercise that was not previously exercisable and vested shall become fully exercisable and vested, subject only to the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and (B) the restrictions, deferral of settlement, and forfeiture conditions applicable to any other Award granted under the Plan shall lapse and such Award shall be deemed fully vested, and any performance conditions imposed with respect to any Award shall be deemed to be fully achieved based on the greater of (i) target performance level or (ii) actual performance achievement, subject to the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10(a) and any related provisions in a Company-sponsored plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Termination Following a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise provided in the Award Agreement or another contract or under the terms of a transaction constituting a Change in Control, upon a Participant&#8217;s involuntary termination of employment without Cause within twenty-four (24) months following the Change in Control, provided that such termination does not result from the Participant&#8217;s termination due to death or for disability, (1) any Award carrying a right to exercise that was not previously exercisable and vested shall become fully exercisable and vested, subject only to the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and (2) the restrictions, deferral of settlement, and forfeiture conditions applicable to any other Award granted under the Plan shall lapse and such Award shall be deemed fully vested, and any performance conditions imposed with respect to any Award shall be deemed to be fully achieved based on the greater of (i) target performance level or (ii) actual performance achievement, subject to the restrictions set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Sections 7(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">10(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">For purposes of the Plan, a &#8220;Change in Control&#8221; shall have occurred if.</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-14.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">Any &#8220;Person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any entity controlling, controlled by or under common control with the Company, any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of shares of the Company), is or becomes the &#8220;beneficial owner&#8221; (as defined in Rule l3d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 25% or more of either the combined voting power of the Company&#8217;s then outstanding voting securities or the then outstanding Shares (in either case, other than as a result of an acquisition of securities directly from the Company)&#59;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-17.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">during any period of two consecutive years, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in clause (i), (iii), or (iv) of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board&#59;</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">a merger, consolidation, recapitalization, or reorganization of the Company is consummated, or a reverse share split of any class of voting securities of the Company, other than any such transaction which would result in at least 75% of the total voting power represented by the voting securities of the Company or the surviving entity outstanding immediately after such transaction being beneficially owned by persons who together beneficially owned of least 75% of the combined voting power of the voting securities of the Company outstanding immediately prior to such transaction, with the relative voting power of each such continuing holder compared to the voting power of each such continuing holder not substantially altered as a result of the transaction&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, for purposes of this paragraph (iii), such continuity of ownership (and preservation of relative voting power) shall be deemed to be satisfied if the failure to meet </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such 75% threshold (or to substantially preserve such relative voting power) is due solely to the acquisition of voting securities by an employee benefit plan of the Company or such surviving entity or of any subsidiary of the Company or such surviving entity&#59; or</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify;text-indent:-19.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9pt">the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets (or any transaction having a similar effect).</font></div><div style="padding-left:108pt;padding-right:-1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, no event or condition shall constitute a Change of Control to the extent that, if it were, a 20% tax would be imposed upon or with respect to an award under Section 409A of the Code&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that, in such case, the event or condition shall continue to constitute a Change in control to the maximum extent possible (e.g., if applicable, in respect of vesting without an acceleration of distribution) without causing the imposition of such 20% tax.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">For purposes of the Plan, &#8220;Cause&#8221; means a Participant&#8217;s gross misconduct, insubordination, violation of the Company&#8217;s policies, or commission of a felony.</font></div><div style="padding-left:72pt;padding-right:-1pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:-1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Certain Corporate Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:5pt;padding-right:3.25pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a corporate transaction (such as, for example, a merger, consolidation, acquisition of property or stock, separation, reorganization, or liquidation), the surviving or successor corporation shall assume each outstanding Award or substitute a new award of the same type for each outstanding Award&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, in the event of a proposed corporate transaction, the Committee may terminate all or a portion of the outstanding Awards, effective upon the closing of the corporate transaction, if it determines that such termination is in the best interests of the Company. If the Committee decides so to terminate outstanding Options and SARs, the Committee shall give each Participant holding an Option or SAR to be terminated not fewer than seven days&#8217; notice prior to any such termination, and any Option or SAR which is to be so terminated may be exercised (if and only to the extent that it is then exercisable under the terms of the Award Agreement and Section 8) at any time prior to such termination. Further, except as otherwise provided in the Plan, the Administrator may, in its discretion accelerate, in whole or in part, the date on which any or all Awards become exercisable or vested (to the extent such Award is not fully exercisable or vested pursuant to the Award Agreement or Section 8).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:5pt;padding-right:3.4pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also may, in its discretion, change the terms of any outstanding Award to reflect any such corporate transaction, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that (i) in the case of ISOs, such change would not constitute a &#8220;modification&#8221; under Section 424(h) of the Code, unless the Participant consents to the change, and (ii) no such adjustment shall be made to an outstanding Option or SAR if such adjustment would cause the Option or SAR to be subject to Section 409A of the Code.</font></div><div style="padding-right:3.4pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">General Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Compliance With Laws and Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company will not be obligated to issue or deliver Shares in connection with any Award or take any other action under the Plan in a transaction subject to the registration requirements of the Securities Act of 1933, as amended, or any other federal or state securities law, any requirement under any listing agreement between the Company and any stock exchange or automated quotation system, or any other law, regulation, or contractual obligation of the Company, until the Company is satisfied that such laws, regulations, and other obligations of the Company have been complied with in full. Certificates representing Shares issued under the Plan will be subject to such stop-transfer orders and other restrictions as may be applicable under such laws, regulations, and other obligations of the Company, including any requirement that a legend or legends be placed thereon.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Limitations on Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards and other rights under the Plan will not be transferable by a Participant except by will or the laws of descent and distribution (or to a designated Beneficiary in the event of the Participant&#8217;s death), and, if exercisable, shall be exercisable during the lifetime of a Participant only by such Participant or his or her guardian or legal representative&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that such Awards and other rights may be transferred to one or more transferees during the lifetime of the Participant in connection with the Participant&#8217;s estate or tax planning, and such transferees may exercise rights thereunder in accordance with the terms thereof, but only if and to the extent consistent with the registration of the offer and sale of Shares on Form S-8, Form S-3, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or such other registration form of the Securities and Exchange Commission as may then be filed and effective with respect to the Plan and permitted by the Committee. The Company may rely upon the beneficiary designation last filed in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards and other rights under the Plan may not be pledged, mortgaged, hypothecated, or otherwise encumbered by a Participant and shall not be subject to the claims of a Participant&#8217;s creditors.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and any subsidiary is authorized to withhold from any Award granted or to be settled, any delivery of Shares in connection with an Award, any other payment relating to an Award, or any payroll or other payment to a Participant amounts of withholding and other taxes due or potentially payable in connection with any income recognition event involving an Award (including, for example, an election under section 83(b) of the Code), and to take such other action as the Committee may deem advisable to enable the Company and Participants to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award. This authority shall include authority to withhold or receive Shares or other property and to make cash payments in respect thereof in satisfaction of a Participant&#8217;s tax obligations.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Right to Continued Employment&#59; Leaves of Absence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the Plan, any Award Agreement, or any action taken hereunder shall be construed as giving any Participant the right to be retained in the employ or contract of the Company or any of its subsidiaries, nor shall it interfere in any way with the right of the Company or any of its subsidiaries to terminate any Participant&#8217;s employment or contract at any time. Unless otherwise specified in the applicable Award Agreement, an approved leave of absence shall not be considered a Termination of Service for purposes of an Award under the Plan.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt;text-decoration:underline">No Rights to Awards&#59; No Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Participant or employee or independent contractor shall have any claim to be granted any Award under the Plan, and there is no obligation for uniformity of treatment of Participants, employees or independent contractors. No Award shall confer on any Participant any of the rights of a stockholder of the Company unless and until Shares are duly issued or transferred and delivered to the Participant in accordance with the terms of the Award or, in the case of an Option, the Option is duly exercised.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt;text-decoration:underline">Changes to the Plan and Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board may amend, alter, suspend, discontinue, or terminate the Plan or the Committee&#8217;s authority to grant Awards under the Plan without the consent of stockholders or Participants, except that any material amendment or alteration will be subject to the approval of the Company&#8217;s stockholders at or before the next annual meeting of stockholders for which the record date is after the date of such Board action if such stockholder approval is required by any applicable federal or state law or regulation or the rules of any stock exchange or automated quotation system on which Company securities may then be listed or quoted, and the Board may otherwise determine to submit other such amendments or alterations to stockholders for approval&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, without the consent of an affected Participant, no such action may materially impair the rights of such Participant with respect to any Award theretofore granted to him. The Committee may waive any conditions or rights under, or amend, alter, suspend, discontinue, or terminate, any Award theretofore granted and any Award Agreement relating thereto&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that, without the consent of an affected Participant, no such action may materially impair the rights of such Participant under such Award&#59; and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that no such amendment, discontinuance or termination of the Plan shall accelerate the time for payment of any Deferred Shares or other amounts subject to Section 409A of the Code (except to the extent permitted by Section 409A of the Code). Except as permitted under Section 4(b), if the Fair Market Value of Shares subject to an Option or SAR has declined since the Award was granted, the Committee shall not, without stockholder approval, (i) cancel any or all such Options or SARs in exchange for cash or the grant of a new Award, or (ii) reduce the exercise price of any or all such Options or reduce the amount over which appreciation of a SAR is measured&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that such reduced amount shall not be less than the Fair Market Value on the date such reduction is made.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">No Fiduciary Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing contained in the Plan and no action taken pursuant to the provisions of the Plan, shall create or shall be construed to create a trust of any kind, or a fiduciary relationship between the Company or its subsidiaries, or their officers or the Committee, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the one hand, and the Participant, the Company, its subsidiaries or any other person or entity, on the other.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices under the Plan shall be in writing, and if to the Company, shall be delivered to the Board or mailed to its principal office, addressed to the attention of the Board&#59; and if to the Participant, shall be delivered personally, sent by facsimile transmission or mailed to the Participant at the address appearing in the records of the Company. Such addresses may be changed at any time by written notice to the other party given in accordance with this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Unfunded Status of Awards&#59; Creation of Trusts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan is intended to constitute an &#8220;unfunded&#8221; plan for incentive and deferred compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award shall give any such Participant any rights that are greater than those of a general creditor of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may authorize the creation of trusts or make other arrangements to meet the Company&#8217;s obligations under the Plan to deliver cash, Shares, other Awards, or other property pursuant to any Award, which trusts or other arrangements shall be consistent with the &#8220;unfunded&#8221; status of the Plan unless the Committee otherwise determines with the consent of each affected Participant.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">Nonexclusivity of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the adoption of the Plan by the Board nor its submission to the stockholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other compensatory arrangements as it may deem desirable, including the granting of awards otherwise than under the Plan, and such arrangements may be either applicable generally or only in specific cases.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Non-Deferred Compensation Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan is intended to constitute an equity or equity-based compensation plan that does not provide for the deferral of compensation subject to Section 409A of the Code and, if any provision of the Plan is subject to more than one interpretation or construction, such ambiguity shall be resolved in favor of that interpretation or construction which is consistent with the Plan not being subject to the provisions of Section 409A. Notwithstanding the forgoing, if, at any time, any provision of this Plan or any Award Agreement relating to an Award does not comply with the requirements of Section 409A of the Code, such provision will be construed or deemed amended to the extent necessary to conform to the applicable requirements of Section 409A of the Code so that such Participant shall avoid liability under Section 409A. Deferred Shares are intended to meet the &#8220;short-term deferral exception&#8221; under Section 409A of the Code.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt;text-decoration:underline">No Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No fractional Shares shall be issued or delivered pursuant to the Plan or any Award. The Committee shall determine whether cash, other Awards, or other property shall be issued or paid in lieu of such fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or otherwise eliminated.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.73pt;text-decoration:underline">Captions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The use of captions in this Plan is for convenience. The captions are not intended to provide substantive rights.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The validity, construction, and effect of the Plan, any rules and regulations under the Plan, and any Award Agreement will be determined in accordance with the Delaware General Corporation Law and other laws (including those governing contracts) of the State of Delaware, without giving effect to principles of conflicts of laws, and applicable federal law.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt;text-decoration:underline">Recoupment Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Plan to the contrary, a Participant&#8217;s right to receive or retain an Award, to retain any amount received pursuant to an Award (in cash or Shares) and, in the case of Shares received pursuant to an Award, to retain any profit or gain the Participant realized in connection with such an Award, shall be subject to any recoupment or &#8220;clawback&#8221; policy adopted by the Company.</font></div><div style="padding-left:72pt;padding-right:3.4pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:3.4pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt;text-decoration:underline">Effective Date and Plan Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan, as amended and restated, will be effective upon approval of the Board, subject to its approval by the stockholders of the Company if such stockholder approval is required by any applicable federal or state law or regulation or the rules of any stock exchange or automated quotation system as then in effect. Unless earlier terminated by action of the Board, the Plan will remain in effect until such time as no Shares remain available for issuance under the Plan and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;padding-right:3.4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company or, if earlier, until the day before the tenth anniversary of the effective date of a renewal of the Plan. For clarity, the Plan shall be effective until June 18, 2035.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>med-20250618.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a39e9482-de6a-4a85-ae00-b3531b191c37,g:02f5c004-2ec6-4ffd-abf5-acc3458a9ac7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20250618" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20250618">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20250618_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20250618_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20250618_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>med-20250618_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a39e9482-de6a-4a85-ae00-b3531b191c37,g:02f5c004-2ec6-4ffd-abf5-acc3458a9ac7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20250618.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:to="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_73393dfb-7d44-40fc-a710-7a357399448e_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:to="loc_dei_ExchangeDomain_73393dfb-7d44-40fc-a710-7a357399448e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:to="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_049517c7-aee2-4d48-b371-35e580affd42" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:to="loc_exch_XNYS_049517c7-aee2-4d48-b371-35e580affd42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ed7618fc-0c4a-421d-a1fa-8ed0358cd58a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_DocumentType_ed7618fc-0c4a-421d-a1fa-8ed0358cd58a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dc61a586-b290-471e-8e35-6baefb60c11b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_DocumentPeriodEndDate_dc61a586-b290-471e-8e35-6baefb60c11b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_828d25c8-c539-4a37-b80d-3568b5121608" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityRegistrantName_828d25c8-c539-4a37-b80d-3568b5121608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d4ef4408-d0c7-451f-b0f9-6cfb36d1d7d3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressAddressLine1_d4ef4408-d0c7-451f-b0f9-6cfb36d1d7d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_eb3324ed-ce58-42e1-9932-5d5bb21d3beb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressCityOrTown_eb3324ed-ce58-42e1-9932-5d5bb21d3beb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e7959f92-1af2-4a03-a856-031d0279860f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressStateOrProvince_e7959f92-1af2-4a03-a856-031d0279860f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6ac81b6d-b4a8-4e9b-b1d2-2b9de8ee260c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressPostalZipCode_6ac81b6d-b4a8-4e9b-b1d2-2b9de8ee260c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_635946b0-36d0-4eba-98e7-00d1cecabfc4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_CityAreaCode_635946b0-36d0-4eba-98e7-00d1cecabfc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f7048ead-4e38-4e4e-a771-5841a6c02f13" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_LocalPhoneNumber_f7048ead-4e38-4e4e-a771-5841a6c02f13" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e3c64c59-c912-44fd-ac9b-c1a31c393211" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_Security12bTitle_e3c64c59-c912-44fd-ac9b-c1a31c393211" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ead36b6e-c88b-4f34-a5b2-ba21d52d3e2f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_TradingSymbol_ead36b6e-c88b-4f34-a5b2-ba21d52d3e2f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1cbaea71-a627-4701-a38a-d4a02f8fe100" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_SecurityExchangeName_1cbaea71-a627-4701-a38a-d4a02f8fe100" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9856501a-a1e9-4ad7-a44b-3eeef9268cc9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_WrittenCommunications_9856501a-a1e9-4ad7-a44b-3eeef9268cc9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_699b99c9-763c-4d5c-ad4e-8de2d3ac707f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_SolicitingMaterial_699b99c9-763c-4d5c-ad4e-8de2d3ac707f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8db7dea5-458c-4fbc-b6ca-91b9ee07c27f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_PreCommencementTenderOffer_8db7dea5-458c-4fbc-b6ca-91b9ee07c27f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f3e7237f-20bf-4616-a267-dd7fca632cf8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f3e7237f-20bf-4616-a267-dd7fca632cf8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e4e62df0-a882-4b02-8d08-629195add009" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityEmergingGrowthCompany_e4e62df0-a882-4b02-8d08-629195add009" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f73d8f3e-c4f0-4ed7-b078-532c8ed6d112" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityCentralIndexKey_f73d8f3e-c4f0-4ed7-b078-532c8ed6d112" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_daa35b9e-d05c-4f68-b45f-d501d8ea4af8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_AmendmentFlag_daa35b9e-d05c-4f68-b45f-d501d8ea4af8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3292fa15-c0a2-4505-ad75-c3643a188de3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityTaxIdentificationNumber_3292fa15-c0a2-4505-ad75-c3643a188de3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_135b8ad6-4569-49de-8e05-716a1c4decc5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityFileNumber_135b8ad6-4569-49de-8e05-716a1c4decc5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_94f12292-302d-4a26-bb0b-5347dc2708ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityIncorporationStateCountryCode_94f12292-302d-4a26-bb0b-5347dc2708ed" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>med-20250618_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a39e9482-de6a-4a85-ae00-b3531b191c37,g:02f5c004-2ec6-4ffd-abf5-acc3458a9ac7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_6d55b0a6-f63f-4e56-a328-5864e77a02c3_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_11c8d1fc-a78a-4042-8457-68ed72a8aff0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3c0853d6-4093-4edf-988b-030e272b8f99_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_6a3d76e3-723e-4ad2-8516-63ebfd3ba2e9_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_409c2a1e-579c-47a6-8a1d-08224a8fe2ec_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_54727a2d-8898-4ea8-b19c-5820170d860b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_af3744b5-8ab1-4d71-8d8d-a181c3f5f165_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_84db1cc9-efe3-46b8-b3b2-bd866b3cdb03_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5045cbd4-96fc-4a0f-ae08-b44a5c274460_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_734291c7-6b6a-4b91-84c7-4186d743df5d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_daca7873-5d91-4610-b308-24804f21f011_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_d44e1d54-981e-4d3b-b55a-5f1ea9bae747_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_aa0591b1-6349-4ffa-a22a-156de6a5c6ff_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_ed954115-275f-4274-8bfd-e3dd1ce52b0e_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_72331470-9347-4dc6-bf6a-6fa700066aee_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_199b3811-5e1e-427f-a4b0-2bb74dba4118_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_97f3058c-b6e8-40c0-95db-9a42aa4b1507_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_8c0fc6d3-3791-469c-b491-b5e5cd401fd4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_20b9a7d8-392e-426a-ac2e-e06e87f4cd3f_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_023189d8-ebfb-4321-8275-898a57641cdd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cf1c39f9-ab7d-47ab-97ee-a759a6b2d0a2_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2553da4d-c385-4416-b3d3-fd9ebcd7c728_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_c897fa79-1bb0-4ff6-bdeb-64afe8937b5e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_96a7b337-74fd-4318-b1fa-384e5aee7a67_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_4c2e6a6e-9da7-4961-9e8c-b000ce9d2a6b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_a97fd779-3865-41c8-b036-57fe98bb6a01_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_20ce6e2f-36bc-4cf6-aa4a-b2f220b63ecf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>med-20250618_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a39e9482-de6a-4a85-ae00-b3531b191c37,g:02f5c004-2ec6-4ffd-abf5-acc3458a9ac7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20250618.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_6dc2e393-a20a-480c-bf10-6e7a1622bd3f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6dc2e393-a20a-480c-bf10-6e7a1622bd3f" xlink:to="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:to="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_73393dfb-7d44-40fc-a710-7a357399448e" xlink:to="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_049517c7-aee2-4d48-b371-35e580affd42" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_6b890c49-a3f2-4cab-b5b5-891bb46003a3" xlink:to="loc_exch_XNYS_049517c7-aee2-4d48-b371-35e580affd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_7720b0bc-3dec-46fe-bfb6-4a34b0d8e1cd" xlink:to="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ed7618fc-0c4a-421d-a1fa-8ed0358cd58a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_DocumentType_ed7618fc-0c4a-421d-a1fa-8ed0358cd58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_dc61a586-b290-471e-8e35-6baefb60c11b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_DocumentPeriodEndDate_dc61a586-b290-471e-8e35-6baefb60c11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_828d25c8-c539-4a37-b80d-3568b5121608" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityRegistrantName_828d25c8-c539-4a37-b80d-3568b5121608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_d4ef4408-d0c7-451f-b0f9-6cfb36d1d7d3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressAddressLine1_d4ef4408-d0c7-451f-b0f9-6cfb36d1d7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_eb3324ed-ce58-42e1-9932-5d5bb21d3beb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressCityOrTown_eb3324ed-ce58-42e1-9932-5d5bb21d3beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e7959f92-1af2-4a03-a856-031d0279860f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressStateOrProvince_e7959f92-1af2-4a03-a856-031d0279860f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_6ac81b6d-b4a8-4e9b-b1d2-2b9de8ee260c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityAddressPostalZipCode_6ac81b6d-b4a8-4e9b-b1d2-2b9de8ee260c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_635946b0-36d0-4eba-98e7-00d1cecabfc4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_CityAreaCode_635946b0-36d0-4eba-98e7-00d1cecabfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f7048ead-4e38-4e4e-a771-5841a6c02f13" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_LocalPhoneNumber_f7048ead-4e38-4e4e-a771-5841a6c02f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e3c64c59-c912-44fd-ac9b-c1a31c393211" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_Security12bTitle_e3c64c59-c912-44fd-ac9b-c1a31c393211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ead36b6e-c88b-4f34-a5b2-ba21d52d3e2f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_TradingSymbol_ead36b6e-c88b-4f34-a5b2-ba21d52d3e2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1cbaea71-a627-4701-a38a-d4a02f8fe100" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_SecurityExchangeName_1cbaea71-a627-4701-a38a-d4a02f8fe100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9856501a-a1e9-4ad7-a44b-3eeef9268cc9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_WrittenCommunications_9856501a-a1e9-4ad7-a44b-3eeef9268cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_699b99c9-763c-4d5c-ad4e-8de2d3ac707f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_SolicitingMaterial_699b99c9-763c-4d5c-ad4e-8de2d3ac707f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_8db7dea5-458c-4fbc-b6ca-91b9ee07c27f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_PreCommencementTenderOffer_8db7dea5-458c-4fbc-b6ca-91b9ee07c27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f3e7237f-20bf-4616-a267-dd7fca632cf8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f3e7237f-20bf-4616-a267-dd7fca632cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e4e62df0-a882-4b02-8d08-629195add009" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityEmergingGrowthCompany_e4e62df0-a882-4b02-8d08-629195add009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f73d8f3e-c4f0-4ed7-b078-532c8ed6d112" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityCentralIndexKey_f73d8f3e-c4f0-4ed7-b078-532c8ed6d112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_daa35b9e-d05c-4f68-b45f-d501d8ea4af8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_AmendmentFlag_daa35b9e-d05c-4f68-b45f-d501d8ea4af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3292fa15-c0a2-4505-ad75-c3643a188de3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityTaxIdentificationNumber_3292fa15-c0a2-4505-ad75-c3643a188de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_135b8ad6-4569-49de-8e05-716a1c4decc5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityFileNumber_135b8ad6-4569-49de-8e05-716a1c4decc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_94f12292-302d-4a26-bb0b-5347dc2708ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_496d75eb-20c5-4058-8f5f-fb908ec3a929" xlink:to="loc_dei_EntityIncorporationStateCountryCode_94f12292-302d-4a26-bb0b-5347dc2708ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 18,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDIFAST, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="med-20250618.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="med-20250618.htm">med-20250618.htm</File>
    <File>med-20250618.xsd</File>
    <File>med-20250618_def.xml</File>
    <File>med-20250618_lab.xml</File>
    <File>med-20250618_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "med-20250618.htm": {
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20250618",
   "dts": {
    "inline": {
     "local": [
      "med-20250618.htm"
     ]
    },
    "schema": {
     "local": [
      "med-20250618.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20250618_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "med-20250618_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20250618_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.medifast1.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20250618.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20250618.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNYS",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC.",
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001628280-25-032457-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-25-032457-xbrl.zip
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MY2;.H]%$JS(2C"JA"=C1*IGZYI]-9_.3,3'QO?^]KD I9N ,3,&W,JX0A@G
M;J[AF.;_H@G0]"WO;/JK3>X6!9P'"P4NT4R#A.2ZA0U)X0.TYH/#'TX&C#7
MQ2@4RQH,A4:C'V+E:^8FPMX)#Y)Y4<(-K8T/A_H2+R"APUN@1X9?\/7H7:UT
M5LP+#*+* 0,/IM!%OX+[T2'F#<WZ4SFX+ LX\^8I_U!M_I7X+.B'5K7_WMYJ
MXKN"_W8+3@P(^?AOZ#Z5/4B#R]U*C V#XS2/1&5DTU$9!W%>?E_#<3$M;4%#
M0N/Q=0%"V=7_JL\]]:V:3V>K'L+I]JK.]QKQ'F[4M^BG8DSLG;[558_[,Z=8
M^,57+[],R866>/B\J9=)!Z/!DP;_>P[7@!,.9AN'SM ZI&!;*V$RWNZY%H]?
MP_ETTY>*O5<Z,?A$0N<)CB&X35LW[A:MA!NC:[KZD<B.GH[L'(2:MZ;.M"3H
ME1^G=N:8['\Z"%(;\68K""PN]H;XF,CL12!N2[4&VRTR'MV10G'^95$5;><%
M"QZ)1,RG(Q&7YQ?3EX@W'S,.]EUE$XH2X*:\UED/CDP!S_ 'R0?+TV>?X& )
M;FL.&/RBZ4NX#!,Q?7E# K3S44-7/JY#YF8Z(G4(!MH/JFB2GU3S07?)WS"S
M-P6QHA0B@P](PDAZ\$.0BQOP]ZLDAWW. 69, E+.4+$48#C.N[YF[QH'^'_K
MYD-RC5E!)TMS<SSA#>&L2I-B;CY8)W<*_?L.;M8UBO(T\.GFQYK,J1_=\"[$
M7]6-C:/GC\=_7QQE[D'X%!?/F8*T2:A; GW)W:+FTZH:0A[2)!?W/B7(@UZN
MRGJ-QI^%0.B5I@UI@^08"0_S<?")<A@($*@%/(XBB#:1*2'Q*$4D$<=&+U6!
M^<"^:SLXQV#U'XD@%=,1I,OS%T^G+TD>!.;/M2KW"@D8&H7U[%?,AH+\W,#@
M<-_C?T&T5JNRR-2L'&:.;("7<^%P&]5)ZE0OG6\41,'!>RJ6J[KI,-".)B7\
M0&R^,=&#__@ I#A.1VEW=_]VH<J2PLVSLF@Y!B\1]LQ[00M6PD-0*T0.N)>D
MMY^3V/N@)?B[J,%79*FN-+P>GK;P.GU5X*\XZ@]WA>?1F]&-O=FB##4#E1 -
ML-"M&TD:313ZF3W"'BM25X0@DE=W2>H9XJYQWC(PYF%XBK+2R4EQ"L]N$)R$
MFFI.U\+KS#OMD _P0/41GPLZ$)1DP0XRVMD*'M85_Z0/4KC9I[L;J&CXMFT-
M^ .F%,T.=4/O5H%11P8*/=1_*OR.06'XS>UI4L,'/(F9@D6>PW3 -_ %> 9]
M4Z$9552W,"QX4*961:=*_+[P?^ #KOXCT?_HBVY-/X)?+=G"9#O)>[@L5I[H
M0K*EB9JU==EW!EJ $],2-DXU!E6RTO#3FZ;N5WQ_>(!]5;P _]%P> _?[Z,_
M2G].X OPB.9%A^.[0;P?W+0UM\ ?%/[4F!_!QP5=F?>X^?DU/](P[A"23[-(
M<Y1H/#<+<.SX)S"AL&"Z:C4?CS4IA9./\+F#U)BM!RN/4\" "9)R$"G"TZ&M
M&BL"EMO!_J5MCZ*X-IK!X>H0C8I_M[0M%4TR2$?5;4(<FKMS$K#>!''T)6R+
MIJ'-+-$?5JP"0G9[>G0[,/KG5IL1^"K%8IT",&;#^Z<J>'NHB@R5CYN-!K_(
M806&/IT[YKF#L@=SU:SNNGKY]1-WB1G\0RLE^/\7C3-B;O39#/3<AS/2$E^K
M\DZMVR\^4W7&0=E,OQYMI@?93.]Z.)$OOIR=/9V.L13$MMP 4?,/@F6H%$"M
MHD5 IV%@2UE/ ;_R#(7VD3@('Z:SV0_!TZ88T'2VN:+C&HP0B4T-CT,O5=*Z
MB+++DN!QVA5=CT>EC5W)W9H-5Z_ZINW%-9CH,DT!^0J6_E??3'2"I*1CKYB/
M=*)SLZCOP-1O]CLUY*;+^0-#11L:13HK%?O@&<M]RWA]%%<PYO("K?)&Y71Z
MD7?G'&T0<$^&V7]*6<+#F[&#'F90E22E^!>H**3HK[55?X\HBUI.YU \" OP
M/7F5MKCK6C>WX)9/YIAT(9<X_&/#PGZ-266CT*D%4GIO1Q))/R#<-3MQ=46E
M:C/=W6G!7]I0MJEL\(]EE##S[[!XCX(Y.XYS/#J^<=0MKPMHBP9M8QJ^/^(-
MP?:'C1^_Y=C03B^15'5U9J?*)0,H)08^>_ "00I;WJ;E.)6Y<LP&VC38XP%]
M/*!_VP%=S#?BJ1%.W;<)NZ'B=3J]LDER,5 X)A &Q"&V.-];P^%9B)]J@.M7
MXQ6#P\BU*>JE]ZCJ9%R')W4&)L/8B2]N<5]U1;EQ$BJ8;1FLC[>_5S*M]M+M
M>?+#F+6!OV8CGS+LXRF/0#<7,@8U?.*:U1;F"OP1GA3G^CR-7PYO%)P1#UY+
M0A,,!S$VAM/AX]D\*RI8%[C-AF6[PRH LNVP,KL#PU&KEK% &/8=G8*^*C'0
M&VX5&S)N>>_=%>T6D,$?H;;YZ72,PWMKFZ\$Z,C?[+6\^7%X!I,KQ+R/84,2
M!Z@;)H'^'<\&@]IL89LF;5TB_P(J^;O:IGS\U LE;.'[NP6<I]935:;@&Q3N
M0-\:7T %9<44%"XQ*(P56I'6RU2%BICJ*[5 MK ZTZ&(^=%4JD:027Q% [=O
M5_@ZLZ)D5[N.[QZ"*=U1'56M/I80\]3J-[<JS+Y;U T>F/&J[5]HR-YR6]YB
MV$= '.-21KMUWL-?N.] $A3\95\8@TWJ@XZ+[#,AF, D"<I>!G8$F@V_6J\N
M-^)+Q9?&S/.0P9Z]^(":_(LG+W?9U\_.+U\<X55??X5S@$A07>+"^)DJ7"52
ME^(;2.1?O'!R@C_IBKPX?_)L?RLRO26Q)C3'9=8K2JW@?TDT#"ZK]A9E#)KT
MZ1?JJ_.7%WM<J*FO5-4O9[K9M$1I]!L)C9.L(?K,1KON"E"XY(EZ\<36Z,W<
M(_L!?RP,D$5@54?ODR:SOB.SI!2>GZY.)5>@FPQ\-$9&I7PK\P]VI+.%<M_C
M0QLA!R([L7&CXF_;;*%S-);P:@\9XPW>X-1+M6(:0.^.;7#+D&H'_)*JG>M&
MD:T$+BC<:*Z+KF_T ,9&+Y*:][-78))2=UW)T4R:19Y$=NGO5'&K&PQ+9AEH
M1C[P&6ZTK'.$'/J%D?4\M91FWFEG:OSIF,O-34Q.)#YE[28Z36V,@\,V2P4_
M:\P^\L!8\#2X=R5)2R%$XM?X'%*_SP/S=L)"?[<@1JJ4A5AUDGA+/3.=/LZ*
M)NN7B!2G\+,1=)-1I^V8,Z1M()'^%C57K%21DX&%4,G4\G'QIKD2OBS+_X*(
M/=W(WH]OE>&8Z.DB2C*0MF\:#%$UG^/ _Y*!&WO94-/;3P@US)IB9BSI9HEK
M3MHD<O#&@,I(X@,GOL";?P\;8(_:X'9Z)H#*ZQ5*/%968G:\7=$?=(X8]LXV
M*PRRA@L>XRI[@9'5!;X3D=[=H#\_/#%0:A&'#UN DEU,\J+R6SSA!,P_K%7^
MY+O@\G*?)OOM!"W!K&X:!@3B A$VD+0HX9Y]U#3.(U<B8'9F6;2M6%%P>5UE
M1:GI&[#<C(^<K0U?J<45T@.)UHNSQ039!SW2A3^S!F(ZON_2H8(98PVSX:>4
M30UKV\ /,K>![2",A416"[Y4V;>8:L(?S0JJEB*L"=@Y0NWD>&PQ78"V%W+)
M<A9YJ3X6RWY)LTH%RG@1B0.%,4IU=TS+WL.HB"F[**5G4U[^.HXLH]BH<MA0
M;JAD=].MAZD*(;-[C U3?\ST*D8G41YQQZU$=;@JQVME,X%4P>(?X?,[P.<W
MJ?0]:>^E1@]X),I]MZAIH?WH/7Z&N U&E'GGH-Q$G#ZZ4;SM/OVI]VR?\8_;
M*09 EA@ =@XKZ$"/W,$X2L[]%:>CP=*L)HA72&V-!Q3@LJN'F3\FKJ""-&84
M3X:S D;W>(SBXN.TML5;@;/=V@ ++%K1KGKB-\ _+9$IK; I"@N.G6@GR&W0
MBDD]"R9A1I%,YWW#X2IEZ4O^T>N6@U*6(;J>P1I*&6-3$'L"P6Q,21<?;"$(
MQFSI@;Y*S;&F6H.-X<!,J;#(DZH.4Y=^D>R)9P(QQ:,S@LZ3OS*@PAE"4H=6
MKMT3/&,L&LX0/K<V03"4&QM60(9*6(0,YAK?RTLNLOE()2[RMFP?LE3!Z85'
MUXY)QGM.G0?@.Z:>KIP<=^0V>_0G554<?WYC]H.?Z4]L/G._Z4N1!)=L+"RK
M:@8B0R%H-@M$8#G)ON4\L>(2UI.NP7_@8)E7Q@6?Q0@X+R'JR0YF7<PTNK&&
M4?CSY K!:UDWID0&0FN57J@X4L^/2K<X4C[5O_>^Z;8JV#1(_G$,7Y@X0)<5
M2V:(7AO(0I1C, JT6S1U?\/$_ $/-145>879G&H6S2;I!E'OMJI_5=]IO[[7
MJ#C+^:ZHQEDND[F-<]IIZ+L8AYDL2<J"F!?CI^$6V)C,AT$'SDO@@F[?.6RS
ME/J&O/_:]6[!<)U 3^YE2>!7L^-+_82ZSXE_3X8A)5 [QAPY+Q,82I3KKTSZ
M?A16'F2)<5Z]85C:?=O$P:^I3/VG>E5B]HE#T=A@_=E7V0P<#X8Y.L1//IS(
MN8TJPND)[MZ4X</I@S'WI6U'4]:MY/50JRRI4X>(FU>1ZH5);E51.KL7<V."
MOL!=2<^TIL7;N0D<^05"=N,BC[PX5<,WIP+^S!AK)BD5Z8%(.[N<'8V#;TW#
M@ >Y6Q?M5MK%K#,F?6N[AK5'5-6CX W>9J50,QKK"/Q82/9VOS;)&V4W\G S
MV>/:#Y&!7-_4=9[,58&,[0U!%1O:UFS\4RX=>7/\N"LI#B:>[YN*"_'@9HMB
M28<-G@Y\A+B+' O6/<?(N!44 -(UZ$[BKE_UX"YE%(SMJXYM [FAH^4*6H;A
M$0OZC(Y]// 0I]E7K2[#;.1<4]!;E=+D+,"CT;A1]EL">(IJW.S0GR<_;]1<
MJ-6:>,8VS16J3K:G9AH6<SYR-[O(K%9)U96%U<#.%DG#V$=JVQ,Y!Q>A<^2_
M4EPSV"D;C4*'#]@81#-A_T_QPC0Z>9# '7@*TN%I%P3D"<&Q@$,8O=090PB9
MFFU9T=Y*0?F6X,NJ9LEV/HP:-D:GLVZX&<;\6DZ2[3C7.RKPRZ<8+)9/Z"0!
M??V)?%BJ4=CIWI,Y+YX=T'DA6*HK:Q#]E4YS%_![:V/*<KR[$T:J^JYR7  Z
M\(]E#W^LL@?9/>],2 %U.:-H]FMP7'N@:;L[T0I'70SJ;B[]+2DP*%#!&CF_
M!B!#&RVAXR%P&XH6J3FX@U3@-XU@S 36Z'4-C'7SV^N_M*<#U\ 4H#584X;J
M_?GS)RG,GH>!I!3YQP(,'S22+M*+%\^]7QPSO,?"V]_(C#&&O8UW+Z.K,$0B
M.QU^*@TS_4W/FYRZ7V(3S1 >;RR4L0I,#R**WC_F#^ "V>EYWYB %#C18(VK
M)EEKU9@XAS^H^[MS^LTYQP<8E)J^MG7TV\=Z(8*[:; <:"A+XRB@;R,&NT4>
M%JV/-13THT,SHK]OBGFYZU;==TY-!<CIJ-25=6 ,K"9;T28RS(B,06L2/_S>
MZ@;\$:J6"93DO">(\6BM-#H@'0[3, 'CBW<+@UA>"-$BQO#P#_9W6(,;Z&98
M'B-;#@<+^VO00LP%-3<,]@B*^-<Y!?>5PC6[.UYLPP5_[6A[4#V9+2X(7<[]
MD4L50G=1JE9J;:#N ;IX@.T7(0UW'TJC^NAE3D- OJ#+2#V90:&ZO</>=+A'
M\<TT#2O7)4+K#4^LA#YE5,2)ZL'RF4%5>RFJL9%Q]-?:..9U<L.Y7Z_ Q1;B
M5[_.#%59&]S4=;4+P-=Q61Q%0A'PZ;+.7KMR#)-(6L*.R6L3;*LU,&M4(>EL
M  RTE[.-5A=YDM<]"K7]YD2B(5QD #.GT*7F-3>L;-(O^9333C(.606?ART
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M57H* -W1>CP.IAEZ0N.VI5C_%+:6M0PZ?E]9CYI@2W_9T<9R!1<?>%3W#D+
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M$!O29H^W4@#(=8QNMAVD/(+I>=&T'5L R,D5A&TV%O*?6 QVD)DVM;Z.A8X
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MB\!E^4CBB$719/V2FRVVKH=[4<%'94E@&&>K4Q[GGA*O(^AT$D+_=M!_80(
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MJLP'*QMUI0B&XOW +,M)N"[6IKU\=J)/_0P_== VQ3PNK_.P6\ZC6YK0N.T
MXXQLSOBP)2?F.QH9'XJ*9Z4-8:8A/J9E'EH;(DC%D#/,S!(C08*2(R'S[Z=1
MO\(Y"+-XS-$FT+X\L/!F>LY\HF.RAN[64GW0,=B%MDW!]0TH  Y^E[I<(<>Y
M7' =U8FW"<G*$P3:^--/[LDU,GC)$VO<L"RRSGNR,NRGE"2R)]^1$O%K%SB-
MZ?J7F#P0>AL=!0)Q-D%UBAHPXF$=,1F,I3FU,3;C5#J-%2(&3X^0JRV0JQ'R
M!F^WN0R,OU'SFIP^J@C@7'D'YP*2T![!5(^B#Z?*T6>&LPEDLEX6&7*DDZ52
MQ<Q0;40LY0?L#=N>VSG43>;()_X[GEDNI9RIIEE'4%EK>W O)<5)9<_@LRJV
MY'9%DI8SD>&L1G1P7V[\I>LQ06D=L8K"WJY^C&F:BEH,P39Y<9*?[E5;X\Q.
M<XXNGIRHO<X-YR-P@I"",-YF:="")\C(5?D60J\0*+%#>8*$P+$%%R<U^R&$
M4I 3+#A&4 Q\+>@GY@;#72K&DS?CMV?$"C_$<DX&3<YN"#]-05.,VW:JN0%A
M] =0PD6ES03#$= S^X']@<<@.>@G<Q3S1RKF=J^2 8?!"@<,HVKH\7#& <08
MCYT%/C?3C$_*^(,-:XS$M?;<W>03!?;<Z6 !RRK /MH8PH9I2$W&<XR.M:AN
MP1NJ.L+9;<R(&C^?$YZV?P=\M3Z;USTH]\MGIZ9_A]<$;"R D$;]-VU-MWFT
MA28R*9[+)X^-/[BPU\QW+ RS\X!E-DU.+DZ3HS5[/.;^<-;LY=&:/5JS1S%_
ME&+^>!&@4RN_I-(VK U'Q=.&4"R;%A^8.R8SZ%'@4.X-79IB_MF=BF/VS44R
MD4=6END7W;1UY2?HK1F*N>^^#?*W;7+Q%%0@J:&+9_C7: 61E]\:L$8(,T3&
MFZ*D[)GY!U>[6E,?C,@EF_64;W-)=_]^78.$ MIEP>9%WF>4ED9<&2/V+%&1
M(;=(+!)NIBL]+[HQF@M31Q2DU.\J/),9/V<:B)I_I:8 DC)W!M86W=0@^#C-
M4ZX=KA^3CXP=-I6.14,/;-I%L?*!:<$=3U,J;FC$[.;<H2POOUV&^22ZT8;T
M/-4*E4_SLZ>>U>*OZ>GF5PZ9H**7;?0*4;85N627B,B5!I'H5A6R3;0T8$5\
M:,WHZOK. 1!CS"!57OE4$W*1/PKQ$^-?"O#W! &C_'2&C'H;EO@>Q>%B!#?1
MEW#.+'I9.R4Q \DIV9S'[,SOJ--,%TXVE*GMQ)PZ:V)4 ):,ZA2EA:<COV^I
M/E(R;3-]4U2&<]:ORW?@!/K=]S7A;(U=CM <@Z<-=)]R'^>ZA77DHA^LT%R1
MVJ6'+Q31Y1"_"7&GX94V%A(K/7+.YW,TIL/@1X!8SDJ*3X#M+MC7U()93:'D
M-*U("_ ^F>W5F#S%I<&L;:EM7:U=>IQ+S.5*M 6C*_'O!CAG_T"XX\JEIKXU
MVP$T&)? &]PS;-PS6"8!?Q'4VB*V2:O!?L3&OJB1Y@A>QYTD*@U4I__SL<WM
M5<G!X*-7W?)V=RK L+6U?0\XQ*FU5E0GP!6K1GCLZR%YQ:]U(U 3.[&_B]8\
M1I>#I':RU.#<-V2$M759Y()>@NVC5L2U^T_YA'J.U,V-JN2C@67#,*Y^N504
MN"#ZAT8S_J'E3O:KLN@,_Q1HJ9;V]\@!'O&-^5IUI,I:JACNZK[,S>&-V1.S
MWU[$M4"!G6&-%,>V<M^(C(71]LUM08R<8M?ZUH:/8^/ZA<&X9QI_Z*PT-*_N
MA/6%SP@^H;KZ1M,4C/P41C9XRZT&U?TOM^$E;&7-L,K=*YMG(-+@R52A0Q=*
M/U9BGB>52%4Z5,4K :*'7"OM93V#FI@)F,O*-^5H]=V8CT5W.\#94NZ+'KCZ
M(.:P6&"BJ-7"6!?!VK!6=X[+"5I**ZZVLXIC=)^<;HA5VFID1/02BE<5I70E
MP2J?(UCN<8#E:!NA&NL6L%U0P*DPGS2.+^&RF03XNV$KP3[%1)B4>1G"C-"9
M&ZI"M,=V#P_0\X>'0&... \DO^/%K);JYO.;0<>VC0$<?5O,1JQ<=-QD'TA=
MJ4[* C94;NLM\J(E13%B'C%'IG/MYL:&4-P?#2XUZF9 I#4G-B':,^%)5VZ*
MDH!II3OFM> PF3,ZA$-<)6T!DZL:<2AW)7F9OAJ)*_Z# M[4L5E0N8PDTDP?
M8L];,2E[ZN7!,<BXDS4U49@GH"#0Z\+P-PP@Z=1'L45GVN;G"'N WM8@3R<4
MJ5%!>42N>317=C)7#%^<:6JHMRXUFBLZ=E(]I$86+KMA7)3EAW5MB?+^1)_?
MG ^JC<*V<:;8PB!(*+ 8UF/XK99.[0^1K]5L8MI++A*)+RK[[?%FOR;'^;@M
M_6627QA^,[%V;&35;D =W32PAY)ET>+F[#/:P*#BB?=,W.[;HB['W&U[CQ5X
M[5FAN3\1YDS@"#+\(\E<EW6U/A:D_RL[[ZOI[+R=&RV\DER53MY[W'T'D)=_
M/M@>3\\OG]^_07!?[6E_#$O",SO[OKUUPE5?+3O3^J-"TQ%MA0VAM\A'P;0@
MK"Z[#&BD@KNMT0,W@3H_)I<R"XNU24_3*$[%?L=(L;!P 6+9LN: RRB=>^MZ
M,"A7E1SRWZ]7' @>O\O1DCGV+?LT?<L\R:/<>4ND]2,BF$9EF5@X; "SVKA6
MRF?N(N:;>.>"!+.KA,$&2V:<E77KY54V#("]A-%Z4!^Z6]@>Q3.DY"DH,=AV
ML4=ZGKR-^H@@$R+LW);(/FOO[?RW,/1[U$SEZET;SPOK@!M\/9)=GRO4H"G
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MG)QAJ@G& (;82T=.7AOPJKCXO%XSZF;V*].PY/.B[$^D+Q.XE$9Q07X#*T$
M'!5*A2>+3:8/+8D7CA$8/YORS\&(>FA?-4QB03?I&$6Y^"QT*'#$X:A1 5C(
MQ2LXN$"43!04/M+F,*-0--*Q^D T('2'W)\T/MT GT3D@MV3ZW!(@T]:!.H/
M]*3@?=4PXO]E $L81?Z\5XNM0C\2/<GB+1L!_<=%YZ9]0KHWS9MV=YX,9B:_
M*[/MMEM_7'=N.NTN:5Z<D/:7UJ_-BU_:I'5Y?M[I=CN7%SN_A#]I- "RB<-
M(R=&RP"#NNS4=W[:_U[ES])5["CQGUY>G__]9Y"H!ZO;1JGOI Q%90&!_*WI
MOR^:/SN.4^"EZ_;%#;EN7UU>W[PWY%V-132FX,3&(>DR%TU_8I5(*(A5WO/V
M2=C?>03<@,<-4Q\+'G/H-;5Q2-.-8?K$JI><W<6*D[DD-'UP[M=L%(J8[*6_
M&07CAT4Q87<8>!#R-?/V&PG_)<O<!A;6Y_TK:=*UE:$W[Q]Y\$0?0A<#_$SW
MZ$2?P-IU%DS=I<+Q;^. $:NFR6#*RF+CS3'N;!A\RJ*_9K=@TX/+'E_ FQ0J
MI<+Q>?ND<]KLWFBD<]$R=EB:9E/^7ON! M_B<I'@Q729A$8D&C$7?2&/\(#P
M."+ Z4#_8G]%;!?>VA2O6X9MU]:UQ$NV89=*SUKBV^K*6<4_6.8,I+:^/7I
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M+!JW/>B?H&?<4/=:VZ9*9%Y#R'TP+Z78"[T)_#6(A_[Q_P-02P,$%     @
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MF=FDTJXIM^#WS^JK*5J9]B[I#Q:^67+YINVEPQ)&5$![:ET)LSS/J*/.$Q[
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MRJ7V =?P27?;76M_,Z_Q:Z6M7?<7(3R&IJC#FRJ\MAVF::^8E5H1EQE*1,X
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MH1[(.FK;2VCNBHL<\HSG$<?K(A&**6(SE9,0\NBMXIF/:<\.OJ?@J9%/<_$
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M97-T871E9'-H82YH=&U02P$"% ,4    " !YA]1::0U*M%\5  "#RP  $
M            @ 'M1P  ;65D+3(P,C4P-C$X+FAT;5!+ 0(4 Q0    ( 'F'
MU%K(0>']=@(  &T(   0              "  7I=  !M960M,C R-3 V,3@N
M>'-D4$L! A0#%     @ >8?46A1&2[$/"   ASD  !0              ( !
M'F   &UE9"TR,#(U,#8Q.%]D968N>&UL4$L! A0#%     @ >8?46K6*CTSH
M"P  [60  !0              ( !7V@  &UE9"TR,#(U,#8Q.%]L86(N>&UL
M4$L! A0#%     @ >8?46CU!60RX!P  #SP  !0              ( !>70
K &UE9"TR,#(U,#8Q.%]P<F4N>&UL4$L%!@     &  8 C@$  &-\      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>med-20250618_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:exch="http://xbrl.sec.gov/exch/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20250618.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-18</startDate>
            <endDate>2025-06-18</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000910329</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-06-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">MEDIFAST, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-31573</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-13">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-14">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-15">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
